Lifecore Biomedical Inc
NASDAQ:LFCR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kerry Logistics Network Ltd
HKEX:636
|
HK |
|
C
|
Car Group Ltd
SWB:WN6
|
AU |
|
IFB Agro Industries Ltd
NSE:IFBAGRO
|
IN |
|
Quaker Chemical Corp
NYSE:KWR
|
US |
|
Z
|
Zhejiang Wellsun Intelligent Technology Co Ltd
SZSE:300882
|
CN |
|
Kajima Corp
TSE:1812
|
JP |
|
United Internet AG
XETRA:UTDI
|
DE |
|
Y
|
Yau Lee Holdings Ltd
HKEX:406
|
HK |
Lifecore Biomedical Inc
Intangible Assets
Lifecore Biomedical Inc
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hershey Co
NYSE:HSY
|
Intangible Assets
$2.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
14%
|
CAGR 10-Years
22%
|
|
|
Tyson Foods Inc
NYSE:TSN
|
Intangible Assets
$5.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
1%
|
|
|
Kellogg Co
NYSE:K
|
Intangible Assets
$1.8B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
Kraft Heinz Co
NASDAQ:KHC
|
Intangible Assets
$37.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-5%
|
|
|
Mondelez International Inc
NASDAQ:MDLZ
|
Intangible Assets
$19.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.
